Pharma's Almanac

𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐏𝐡𝐚𝐫𝐦𝐚 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠: 𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐢𝐬 𝐍𝐨𝐰 Back in 1997, the biotherapeutics sector was still in its early days, and regulatory frameworks for biologics were just starting to mature. Fast forward to today—advanced manufacturing is revolutionizing drug development, speeding up approval timelines, and increasing patient access. But what’s driving adoption, and what role do CDMOs play? 🚀 Read more here: https://lnkd.in/eb7T6JRd Tonia Becker | INTERPHEX Global | David Alvaro #AdvancedManufacturing #PharmaInnovation #DrugDevelopment #Biopharma #CDMO

Pharma's Almanac is heading to INTERPHEX 2025 (April 1-3, NYC) to capture the biggest trends, innovations, and success stories in pharma and biopharma. Have insights to share? We’re booking interviews now! This is your chance to position your company at the forefront of industry conversations. Reach out to schedule your interview: https://lnkd.in/e3_NXC_W INTERPHEX Global #INTERPHEX #pharma #pharmaindustry #NYC

𝐖𝐞’𝐫𝐞 𝐛𝐚𝐜𝐤 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐩𝐨𝐥𝐥𝐬! 🎉 Biopharma is evolving fast, and so is the way we consume content. Whether you’re diving into deep scientific insights or prefer quick visual takeaways, we want to know: 👉 𝘞𝘩𝘢𝘵 𝘵𝘺𝘱𝘦 𝘰𝘧 𝘣𝘪𝘰𝘱𝘩𝘢𝘳𝘮𝘢 𝘤𝘰𝘯𝘵𝘦𝘯𝘵 𝘥𝘰 𝘺𝘰𝘶 𝘧𝘪𝘯𝘥 𝘮𝘰𝘴𝘵 𝘷𝘢𝘭𝘶𝘢𝘣𝘭𝘦? Vote below and let us know why in the comments! ⬇️ #Biopharma #LifeSciences #BiotechIndustry #PharmaContent #PharmaNews

🌟 𝐉𝐨𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧: 𝐈𝐬 𝐀𝐈 𝐭𝐫𝐮𝐥𝐲 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐝𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭, 𝐨𝐫 𝐚𝐫𝐞 𝐰𝐞 𝐬𝐭𝐢𝐥𝐥 𝐧𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐭𝐡𝐞 𝐡𝐲𝐩𝐞? 🌟 In this Pharma's Almanac roundtable, a panel of industry experts share their insights on AI's role in transforming drug development. 🔗 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐫𝐨𝐮𝐧𝐝𝐭𝐚𝐛𝐥𝐞 𝐡𝐞𝐫𝐞: https://lnkd.in/ezBER8hW Our roundtable includes a panel of expert contributors: Murray McKinnon, Ph.D., Richard Lee, Alan Marcus, Christian O., Mark J. Kiel MD PhD, Simon Wagschal, Jo Varshney, Seongil Cho, John Lee, Julie Frearson, Venu Mallarapu, Ann Belien, PhD Empress Therapeutics, ACD, LabVantage Solutions, Inc, Dotmatics, Genomenon, Inc, Lonza, VeriSIM Life, Samsung Biologics, SK pharmteco, Charles River Laboratories, eClinical Solutions, Rejuvenate Biomed, David Alvaro #AI #DrugDevelopment #Pharma #Roundtable #ArtificialIntelligence

𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐑𝐍𝐀 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐳-𝐝𝐛𝐃𝐍𝐀™ Efficiency, scalability, and quality are key in RNA-based therapeutics. Touchlight's z-dbDNA™ enhances RNA yields with less template while ensuring a favorable quality profile, making it a game-changer for RNA-based therapies. 🔗 𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐡𝐞𝐫𝐞: https://lnkd.in/erUdrrKV #RNAInnovation #mRNATherapeutics #Biomanufacturing #SyntheticDNA #CDMO Lisa Caproni, PhD Jill Makin Tom Adie, PhD Elena Stoyanova, PhD

Nice Insight is making a big comeback for 2025—just in time for That's Nice’s 30th anniversary! + All of our market research and pricing reports have been digitized for easier access + Monthly updates featuring the latest in clinical trials, pricing, benchmarking, and outsourcing provider profiles + The most comprehensive industry insights—now available online Dive into this new chapter of pharma and biotech intelligence. Explore Nice Insight: https://lnkd.in/ebvt3-WY Nigel Walker | Mark Allen | David Alvaro | April Stanley, MS, MBA | Daniel Smith | Emilee K. | Connor Halverson | John DeGregorio | Sophie Lutter | Mandy Boyd | Pharma's Almanac #NiceInsight #MarketResearch #Pharma #Biotech #ClinicalTrials

🌟 𝐉𝐨𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧: 𝐖𝐡𝐚𝐭 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐚𝐫𝐞 𝐞𝐧𝐬𝐮𝐫𝐢𝐧𝐠 𝐬𝐮𝐩𝐩𝐥𝐲 𝐜𝐡𝐚𝐢𝐧 𝐫𝐞𝐬𝐢𝐥𝐢𝐞𝐧𝐜𝐞 𝐢𝐧 𝐚 𝐩𝐨𝐬𝐭-𝐂𝐎𝐕𝐈𝐃 𝐰𝐨𝐫𝐥𝐝? 🌟 In this Pharma's Almanac roundtable, a panel of industry experts share their insights on supply chain vulnerabilities during the pandemic, and key strategies to overcome them. 🔗 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐫𝐨𝐮𝐧𝐝𝐭𝐚𝐛𝐥𝐞 𝐡𝐞𝐫𝐞: https://lnkd.in/ezhaFVc9 Our roundtable includes a panel of expert contributors: Jordi Robinson, Chris Neasham, Selwyn Lustman, Mark Przekop, Yongkwan Ma, Arvind Singh, Pierre-Alain Ruffieux Navin Molecular, Sterling Pharma Solutions, LGM Pharma, Nucleus RadioPharma, Samsung Biologics, SK pharmteco, Cytiva #Pharma #SupplyChain #Biopharma #COVID19 #SupplyChainLogistics

INTERPHEX 2025 is just around the corner! Join the Pharma's Almanac team April 1-3 at the Javits Center in NYC, where we’ll be conducting exclusive on-site interviews with the most innovative companies in pharma and biopharma. Have a story to tell? Let’s make it happen! + Share your insights with our global audience + Highlight your company’s role in shaping the future of pharma + Get featured in Pharma’s Almanac and across our digital platforms Reach out now to schedule your interview: https://lnkd.in/eaB2ZDdk That's Nice | INTERPHEX Global #INTERPHEX #pharma #pharmaindustry #NYC

𝐂𝐮𝐭𝐭𝐢𝐧𝐠 𝐂𝐨𝐬𝐭𝐬 & 𝐓𝐢𝐦𝐞𝐥𝐢𝐧𝐞𝐬 𝐢𝐧 𝐱𝐑𝐍𝐀 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 How can we make xRNA therapeutics and vaccines more accessible?ReciBioPharm’s Aaron B Cowley shares how our continuous manufacturing platform is transforming development by: ✅ 𝘙𝘦𝘥𝘶𝘤𝘪𝘯𝘨 𝘤𝘰𝘴𝘵𝘴 ✅ 𝘚𝘩𝘰𝘳𝘵𝘦𝘯𝘪𝘯𝘨 𝘱𝘳𝘰𝘥𝘶𝘤𝘵𝘪𝘰𝘯 𝘵𝘪𝘮𝘦𝘭𝘪𝘯𝘦𝘴 ✅ 𝘚𝘵𝘳𝘦𝘢𝘮𝘭𝘪𝘯𝘪𝘯𝘨 𝘴𝘤𝘢𝘭𝘢𝘣𝘪𝘭𝘪𝘵𝘺 Innovation that brings life-changing therapies faster and more efficiently to patients. 🔗 Read more here: https://lnkd.in/eu_3CHTj #xRNATherapeutics #RNA #ContinuousManufacturing #BiopharmaInnovation #CDMO Daniel Spurgin Nathaniel Youndt, MBA Jing Zhu, Ph.D.

𝐋𝐚𝐛𝐜𝐨𝐫𝐩 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐬 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐨𝐟 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐓𝐞𝐬𝐭 𝐭𝐨 𝐆𝐮𝐢𝐝𝐞 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐏𝐥𝐚𝐧𝐬 Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the clinical availability of Labcorp® Plasma Complete, a circulating tumor DNA (ctDNA)-based comprehensive genomic profiling solution for patients with advanced solid tumors. 🔗 Read more here: https://lnkd.in/e_ek4EJZ #Pharma #LiquidBiopsy #ctDNA #GeneTherapy #Innovation